clinicaltrialsarena2h
Shuttle Pharma announces glioblastoma trial expansion
As the first cohort of patients are dosed in the Phase II trial, multiple new trial sites are added for the glioblastoma ...
clinicaltrialsarena6h
SELLAS announces data indicating key predictor of response to SLS009 in solid cancers
SELLAS has announced positive data from preclinical studies identifying the ASXL1 mutation as a predictor of response to ...
clinicaltrialsarena23h
Anocca submits application to EMA for pancreatic cancer trial
Anocca has submitted its first clinical trial application (CTA) for conducting the Phase I/II VIDAR-1 trial to the EMA.
clinicaltrialsarena23h
Aulos Bioscience doses first patient in avelumab lung cancer trial
Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as ...